Stenoparib

TARPON SPRINGS, Fla., June 30, 2026 Allarity Therapeutics, Inc. announced that the U.S. Patent and Trademark Office (USPTO) has...

COPENHAGEN, Denmark, June 18, 2026 Allarity Therapeutics, Inc. announced the presentation of a Trial-in-Progress poster for its ongoing Phase...

TARPON SPRINGS, Fla., March 6, 2026 Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, has announced the successful closing of...